Ocular Therapeutix outlines Q4 2026 AXPAXLI NDA plan with $530.6M cash runway into 2028
Seeking Alpha · 市场快讯 · November 9, 2026 at 12:51 PM ET
Read the full report at the original publisher.
Seeking Alpha · 市场快讯 · November 9, 2026 at 12:51 PM ET
Read the full report at the original publisher.